The Board of Directors of Episurf has resolved on an issue of Class B shares and convertibles as part of the consideration for the acquisition of property assets

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, ISRAEL, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, THE UNITED KINGDOM, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR DISCLOSURE WOULD BE IN VIOLATION OF APPLICABLE LAWS OR REQUIRE ADDITIONAL REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO THE SECTION "IMPORTANT INFORMATION" AT THE END OF THIS PRESS RELEASE.  The Board of Directors of Episurf Medical AB (publ) ("Episurf" or the "Company") has, on 31 August 2026, as…

Episurf accelerates its transformation into a pure-play property company and concludes the strategic review of the medtech operations

Episurf Medical AB (publ) ("Episurf" or the "Company") is accelerating its transformation into a pure-play property company and will going forward concentrate the Company's resources and capital allocation on the Nordic property operations. As part of this, the board of directors has, within the framework of the previously communicated dual-track process, resolved to initiate an orderly wind-down of the operational medical technology business. The Company assesses that a sale or spin-off of the business in…

Episurf Medical enters into a letter of intent regarding the acquisition of a property portfolio with an agreed property value of approximately SEK 505 mn

Episurf Medical AB (publ) (“Episurf” or the “Company”) has today entered into a letter of intent regarding the acquisition of all shares in five property-owning companies. The agreed underlying property value amounts to approximately SEK 505 mn before deduction for deferred tax. The parties’ objective is to enter into a final share purchase agreement no later than 30 September 2026, with completion planned for around 1 November 2026. The portfolio consists of five modern, newly…

• Release

Episurf Medical has entered into an agreement for the financing of the Lilium and Setune acquisitions and closing of the property acquisitions takes place on 31 August 2026

Episurf Medical AB (publ) ("Episurf" or the "Company") (Nasdaq Stockholm: EPIS B) has entered into an agreement for the financing of the previously communicated acquisitions of the property portfolio comprising 45 properties from Fastighetsaktiebolaget Lilium (the "Lilium Acquisition") and the property portfolio comprising four properties from Setune Assets AB (the "Setune Acquisition", and together with the Lilium Acquisition, the "Acquisitions"). The closing of the Acquisitions will take place on 31 August 2026. "We are pleased…

• Release

Change in number of shares and votes in Episurf Medical

As a result of, in accordance with previously announced information, the directed issue of 2,888,888,888 Class B shares resolved on 3 July 2026 as well as the directed issue of an additional number of 868,702,560 Class B shares resolved on 8 July 2026, the number of shares and votes in Episurf Medical AB (publ) (“Episurf”) has changed. Through the above-mentioned changes, the total number of shares in Episurf as of 31 July 2026 amounts to…

The Board of Directors of Episurf has resolved on an issue of Class B shares as part of partial closing

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, ISRAEL, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, THE UNITED KINGDOM, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR DISCLOSURE WOULD BE IN VIOLATION OF APPLICABLE LAWS OR REQUIRE ADDITIONAL REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO THE SECTION "IMPORTANT INFORMATION" AT THE END OF…

Episurf Medical completes the first partial closing of the portfolio announced on 5 June 2026, acquiring properties with an agreed property value of SEK 301 mn

Episurf Medical AB (publ) (“Episurf” or the “Company”) announced on 5 June 2026 the acquisition of a property portfolio of 30 properties in Södermanland and Östergötland, with an agreed property value of SEK 920 mn. Closing of the portfolio takes place in several parts. The first partial closing is carried out today, 7 July 2026, and comprises properties with an agreed property value of SEK 301 mn. The partial closing in brief The partial closing…

The Board of Directors of Episurf has resolved on an issue of Class B shares as part of the consideration for the acquisition of property assets

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, ISRAEL, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, THE UNITED KINGDOM, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR DISCLOSURE WOULD BE IN VIOLATION OF APPLICABLE LAWS OR REQUIRE ADDITIONAL REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO THE SECTION "IMPORTANT INFORMATION" AT THE END OF…

• Release